Patents Represented by Attorney Lawrence Flynn

Find this attorney in the Justia Lawyer Directory

  • Therapeutic method for treating blood-clotting defects with factor VIIa
    Patent number: 4382083
    Abstract: Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably, the factor VIIa is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described.
    Type: Grant
    Filed: June 25, 1981
    Date of Patent: May 3, 1983
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventor: William R. Thomas